I am a medical oncologist who specializes in treating patients with blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome. I received my doctor of medicine from the Washington University School of Medicine in St. Louis and completed my fellowship in hematology and oncology right here at The Ohio State University. As a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, my primary research focus is on myeloid malignancies, specifically working to better understand how leukemia develops and how leukemia cells respond to novel targeted therapies. Current research projects include pre-clinical investigations of BET inhibitors in combination with other targeted therapies in pre-clinical models of acute myeloid leukemia and basic investigations into the role of BET proteins in leukemogenesis. This works relies heavily upon the use of primary patient samples procured by the Leukemia Tissue Bank, both in in vitro assays and patient-derived xenografts. I’m very passionate about seeing discoveries from this research translated into improved treatment options for leukemia patients at The James and around the world. In addition to my clinical work and research, I serve as an assistant professor in the Division of Hematology, Department of Internal Medicine at Ohio State. I am also a member of several professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology and the American College of Physicians. I am honored to be a part of the OSUCCC – James. The close collaboration between everyone in the hospital is truly unique, and it’s rewarding both personally and professionally to be able to work alongside a diverse team of smart, hardworking clinicians and researchers who are focused on improving the lives of leukemia patients and achieving our ultimate goal of a cancer-free world.